CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today the election of Marsha H. Fanucci to its Board of Directors. Ms. Fanucci is the former Chief Financial Officer of Millennium Pharmaceuticals. She currently serves on the Board of Directors at Ironwood Pharmaceuticals, Inc. and Momenta Pharmaceuticals, Inc.
